Eton Pharmaceuticals, Inc. (ETON) Reports Q4 Loss, Lags Revenue Estimates
ETONEton Pharmaceuticals(ETON) Zacks Investment Research·2024-03-15 06:16

Eton Pharmaceuticals, Inc. (ETON) came out with a quarterly loss of 0.09pershareversustheZacksConsensusEstimateofalossof0.09 per share versus the Zacks Consensus Estimate of a loss of 0.04. This compares to earnings of 0.04pershareayearago.Thesefiguresareadjustedfornon−recurringitems.Thisquarterlyreportrepresentsanearningssurpriseof−1250.04 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -125%. A quarter ago, it was expected that this company would post a loss of 0.10 per share when it actually produced a loss of $0.02, delivering a surprise of 80%. Over the last four quarters, the company ...